The George Institute for Global Health, Australia
The George Institute for Global Health, Australia
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 3 | 2026-07-07 | NCT07687056 | |
| Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation | Hypoxia, Hypoxia, Brain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, central nervous system disorder, nervous system disorder | Active, not recruiting | Not applicable | 2026-06-02 | NCT05564754 | |
| International Care Bundle Evaluation in Cerebral Hemorrhage Research | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 4 | 2026-05-22 | NCT06429332 | |
| ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2025-09-17 | NCT06320431 | |
| Stepcare Extended Follow-up Substudy | Cognition Disorders, Cognitive Dysfunction, Hypoxia, Hypoxia, Brain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, central nervous system disorder, cognitive disorder, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2025-04-23 | NCT06207942 | |
| Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients | Solid Tumor, Adult | Recruiting | Phase 2 | 2024-11-15 | NCT06003621 |